"Oh, and there was a nice little rider in the next presentation. Some people might think that developing clonal technology—the thing that really works—for the very rich and then letting it trickle down to the rest would benefit everyone. Producers get economies of scale, consumers get what they need. However, it turns out that you can’t dispense the new products to the mass market because then the corps wouldn’t have big enough production runs for their simpler, cheaper products. Longterm profits would drop, discouraging further research.